A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 237.12 USD -0.01% Market Closed
Market Cap: 49.1B USD
Have any thoughts about
Amerisourcebergen Corp?
Write Note

Amerisourcebergen Corp
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amerisourcebergen Corp
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
Amerisourcebergen Corp
LSE:0HF3
Additional Paid In Capital
$6B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
Cardinal Health Inc
NYSE:CAH
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Henry Schein Inc
NASDAQ:HSIC
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Additional Paid In Capital
$272m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
59%
Mckesson Corp
NYSE:MCK
Additional Paid In Capital
$8.2B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
2%
Cencora Inc
NYSE:COR
Additional Paid In Capital
$6B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
8%
No Stocks Found

Amerisourcebergen Corp
Glance View

Economic Moat
None
Market Cap
46.2B USD
Industry
Health Care

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
434.05 USD
Undervaluation 45%
Intrinsic Value
Price
A

See Also

What is Amerisourcebergen Corp's Additional Paid In Capital?
Additional Paid In Capital
6B USD

Based on the financial report for Sep 30, 2024, Amerisourcebergen Corp's Additional Paid In Capital amounts to 6B USD.

What is Amerisourcebergen Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
8%

Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for Amerisourcebergen Corp have been 3% over the past three years , 4% over the past five years , and 8% over the past ten years .

Back to Top